AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2017

May 3, 2017

30339_dirs_2017-05-03_ef6aa2c2-2894-4e14-9d3a-f1d47104224a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-05-02

Reporting Person: LAI GOLDMAN MYLA (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-02	Common Stock	A	1697.00	$0.00	Acquired	9528.9468	Direct

Footnotes

F1: These shares of restricted stock units will vest in full after 12 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.